tetradecanoylphorbol acetate has been researched along with artemisinin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Fan, YQ; Huang, ZQ; Meng, S; Wang, CQ; Wang, LS; Wang, Y; Zhang, YC | 1 |
| Cao, J; Chen, T; Fan, Y; Huang, Z; Jiang, R; Meng, S; Wang, C; Wang, L; Wang, Y | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and artemisinin
| Article | Year |
|---|---|
Artemisinin inhibits extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase-9 expression via a protein kinase Cδ/p38/extracellular signal-regulated kinase pathway in phorbol myristate acetate-induced THP-1 macrophages.
Topics: Anti-Infective Agents; Artemisinins; Basigin; Cell Line; Down-Regulation; Drug Evaluation, Preclinical; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Humans; Macrophages; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; p38 Mitogen-Activated Protein Kinases; Protein Kinase C-delta; Signal Transduction; Tetradecanoylphorbol Acetate | 2011 |
The anti-malarial artemisinin inhibits pro-inflammatory cytokines via the NF-κB canonical signaling pathway in PMA-induced THP-1 monocytes.
Topics: Anti-Inflammatory Agents; Antimalarials; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cytokines; Gene Expression Regulation; Humans; Monocytes; NF-kappa B; Protein Transport; Signal Transduction; Tetradecanoylphorbol Acetate | 2011 |